![](images/graphics/blank.gif)
CCNE1 gains
Xem 1-1 trên 1 kết quả CCNE1 gains
-
Ovarian carcinomas presenting homologous recombination deficiency (HRD), which is observed in about 50% of cases, are more sensitive to platinum and PARP inhibitor therapies.
10p
vikuala271
13-06-2020
14
1
Download
CHỦ ĐỀ BẠN MUỐN TÌM
TOP DOWNLOAD
![](images/graphics/blank.gif)